BRPI0814409A2 - Tratamento de dor neuropática - Google Patents

Tratamento de dor neuropática

Info

Publication number
BRPI0814409A2
BRPI0814409A2 BRPI0814409-5A2A BRPI0814409A BRPI0814409A2 BR PI0814409 A2 BRPI0814409 A2 BR PI0814409A2 BR PI0814409 A BRPI0814409 A BR PI0814409A BR PI0814409 A2 BRPI0814409 A2 BR PI0814409A2
Authority
BR
Brazil
Prior art keywords
neuropathic pain
pain treatment
treatment
neuropathic
pain
Prior art date
Application number
BRPI0814409-5A2A
Other languages
English (en)
Inventor
Michael Lionel Selley
Original Assignee
Nuon Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuon Therapeutics Inc filed Critical Nuon Therapeutics Inc
Publication of BRPI0814409A2 publication Critical patent/BRPI0814409A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BRPI0814409-5A2A 2007-07-06 2008-07-03 Tratamento de dor neuropática BRPI0814409A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94841707P 2007-07-06 2007-07-06
PCT/US2008/008247 WO2009008997A2 (en) 2007-07-06 2008-07-03 Treatment of neuropathic pain

Publications (1)

Publication Number Publication Date
BRPI0814409A2 true BRPI0814409A2 (pt) 2014-10-14

Family

ID=40229336

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0814409-5A2A BRPI0814409A2 (pt) 2007-07-06 2008-07-03 Tratamento de dor neuropática

Country Status (9)

Country Link
US (1) US20090042987A1 (pt)
EP (1) EP2173167A4 (pt)
KR (1) KR20100047860A (pt)
CN (1) CN101730467A (pt)
AU (1) AU2008275752A1 (pt)
BR (1) BRPI0814409A2 (pt)
CA (1) CA2690719A1 (pt)
IL (1) IL202639A0 (pt)
WO (1) WO2009008997A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9034910B2 (en) 2008-06-09 2015-05-19 Allergan, Inc. Methods of treating alpha adrenergic mediated conditions
EP2642989B1 (en) 2010-11-24 2019-01-02 OccuRx Pty Ltd Methods of treating eye diseases associated with inflammation and vascular proliferation
KR20150100923A (ko) * 2012-12-28 2015-09-02 니폰 조키 세야쿠 가부시키가이샤 신남산 아미드 유도체
CN105663104A (zh) * 2016-01-06 2016-06-15 南京医科大学第一附属医院 曲尼司特在制备治疗糖尿病性硬肿症的药物中的应用
US11014873B2 (en) 2017-02-03 2021-05-25 Certa Therapeutics Pty Ltd. Anti-fibrotic compounds
CN115607533A (zh) * 2022-09-29 2023-01-17 华中科技大学协和深圳医院 曲尼斯特在防治化疗诱导的外周神经痛的应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536809A (en) * 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) * 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US5073543A (en) * 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
IT1229203B (it) * 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
US5120548A (en) * 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5591767A (en) * 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
IT1270594B (it) * 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
US5871776A (en) * 1995-01-31 1999-02-16 Mehta; Atul M. Controlled-release nifedipine
DK0770397T3 (da) * 1995-10-18 2004-08-09 Akzo Nobel Nv Newcastle disease viruskombinationsvaccine
US5837284A (en) * 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
AU2001232348A1 (en) * 2000-02-21 2001-08-27 Takeda Chemical Industries Ltd. Sustained release preparations of physiologically active compound hardly solublein water and production process and use of the same
CN1284536C (zh) * 2000-09-18 2006-11-15 威克斯医药有限公司 河豚毒素或蛤蚌毒素及其类似物在制备用于全身镇痛的镇痛药中的应用
US20060100274A1 (en) * 2004-11-05 2006-05-11 Trustees Of Tufts College Therapeutic avenanthramide compounds
CA2609059A1 (en) * 2005-05-16 2006-11-23 Angiogen Pharmaceuticals Pty. Ltd. Methods and compositions for the treatment of pain

Also Published As

Publication number Publication date
US20090042987A1 (en) 2009-02-12
WO2009008997A3 (en) 2009-02-26
EP2173167A4 (en) 2010-07-28
WO2009008997A2 (en) 2009-01-15
AU2008275752A1 (en) 2009-01-15
EP2173167A2 (en) 2010-04-14
IL202639A0 (en) 2010-06-30
CN101730467A (zh) 2010-06-09
KR20100047860A (ko) 2010-05-10
CA2690719A1 (en) 2009-01-15

Similar Documents

Publication Publication Date Title
BRPI0907135A2 (pt) Processos de tratamento de dor crônica
BRPI0916125A2 (pt) "dispositivo de tratamento"
DK2405869T3 (da) Fedmebehandling
BRPI0910854A2 (pt) métodos de tratamento
BRPI0917567A2 (pt) tratamento de doença respiratória
DE602007011342D1 (de) Endoskop-Behandlungswerkzeug
EP1982660A4 (en) TREATMENT ENDOSCOPE
BRPI0821810A2 (pt) Instalação de tratamento por imersão
EP2322076A4 (en) ENDOSCOPE OF TREATMENT
EP2106814A4 (en) TREATMENT DEVICE
DK2310071T3 (da) Ekkogen medicinsk kanyle
DE602008004368D1 (de) Endoskop-Behandlungswerkzeug
BRPI0914294A2 (pt) aparelho de tratamento de cápsulas
HK1255227A1 (zh) 疼痛治療
BRPI0919748A2 (pt) dipositivo de tratamento
DK2173831T3 (da) Brøndbehandling
BRPI0811919A2 (pt) Medicamento para tratamento do mal de alzheimer
DE602008000310D1 (de) Endoskopisches Behandlungswerkzeug
DE502008000740D1 (de) Rollosystem
EP2368499A4 (en) TREATMENT INSTRUMENT
DE602008006133D1 (de) Endoskopisches Behandlungswerkzeug
BRPI0814409A2 (pt) Tratamento de dor neuropática
DK2376121T4 (da) Slidgigtbehandling
BRPI0820449A2 (pt) Conjunto de implante médico interfaceado
BRPI0806944A2 (pt) Medicamento para o tratamento de endometriose

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]